Arvinas, Inc. (ARVN)
12.60
+0.57
(+4.74%)
USD |
NASDAQ |
Jan 21, 16:00
12.61
+0.01
(+0.08%)
After-Hours: 20:00
Arvinas Free Cash Flow
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Verastem, Inc. | -140.93M |
| Genprex, Inc. | -15.08M |
| Olema Pharmaceuticals, Inc. | -134.67M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -59.10M |
| Cash from Investing (Quarterly) | 63.50M |
| Cash from Financing (Quarterly) | -17.80M |
| Free Cash Flow Per Share (Quarterly) | -0.8087 |
| Free Cash Flow to Equity (Quarterly) | -58.60M |
| Free Cash Flow to Firm (Quarterly) | -59.20M |